Total trials
192
Active
78
Phase 3
0
Total enrollment
13,165
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Ketamine | — | — | — | — | — | 1 |
Next readouts
- 2026-06-15
Top conditions
- Postoperative Pain10
- Stroke9
- Hemiplegia5
- Low Back Pain4
- Sports Physical Therapy4
- Obesity4
- Exercise4
- Physical Activity3
Frequently asked questions about Istinye University
- How many clinical trials does Istinye University have on ClinicalTrials.gov?
- Istinye University is listed as the lead sponsor on 192 clinical trials in ClinicalTrials.gov, 78 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Istinye University's trials are in Phase 3?
- 0 of Istinye University's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Istinye University focus on?
- Istinye University's most-studied conditions on ClinicalTrials.gov are Postoperative Pain, Stroke, Hemiplegia, Low Back Pain, Sports Physical Therapy.
- When are Istinye University's next clinical trial readouts?
- Istinye University has 1 upcoming primary-completion readout tracked here; the soonest is “Ketamine and Dexmedetomidine for Delirium in Joint Arthroplasty”, expected around 2026-06-15.